Atlas Trials

Study of Oral Weekly GS-1720 and GS-4182 Compared With Biktarvy in People With HIV-1 Who Have Not Been Treated

Clinical trial NCT06613685 · TERMINATED

Trial details

NCT number
NCT06613685
Sponsor
Gilead Sciences
Status
TERMINATED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
HIV-1-infection
Start date
2024-10-21
Primary completion
2026-03-16
Enrollment
73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.